Literature DB >> 15634964

Comparison of emm typing and ribotyping with three restriction enzymes to characterize clinical isolates of Streptococcus pyogenes.

Stella Z Doktor1, Jill M Beyer, Robert K Flamm, Virginia D Shortridge.   

Abstract

A total of 336 Streptococcus pyogenes isolates recently recovered from patients with pharyngitis from 13 countries were characterized by emm typing and riboprinting using an automated Riboprinter (Dupont/Qualicon) based on the patterns produced by three restriction enzymes, EcoRI, PstI, and HindIII. Three enzymes were necessary to increase the discrimination of ribogroups formed by each enzyme. A total of 40 ribogroups and 38 emm sequences (not counting allelic variations) were identified. Multilocus sequence typing was performed on a sampling of the isolates, and those results were consistent with those of both emm typing and ribotyping. Correlations were observed among all three methods.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15634964      PMCID: PMC540156          DOI: 10.1128/JCM.43.1.150-155.2005

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  12 in total

1.  Multilocus sequence typing of Streptococcus pyogenes and the relationships between emm type and clone.

Authors:  M C Enright; B G Spratt; A Kalia; J H Cross; D E Bessen
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

2.  Comparative evaluation of an automated ribotyping instrument versus pulsed-field gel electrophoresis for epidemiological investigation of clinical isolates of bacteria.

Authors:  R J Hollis; J L Bruce; S J Fritschel; M A Pfaller
Journal:  Diagn Microbiol Infect Dis       Date:  1999-08       Impact factor: 2.803

Review 3.  Multi-locus sequence typing: a tool for global epidemiology.

Authors:  Rachel Urwin; Martin C J Maiden
Journal:  Trends Microbiol       Date:  2003-10       Impact factor: 17.079

4.  Sequencing emm-specific PCR products for routine and accurate typing of group A streptococci.

Authors:  B Beall; R Facklam; T Thompson
Journal:  J Clin Microbiol       Date:  1996-04       Impact factor: 5.948

5.  Survey of emm gene sequences and T-antigen types from systemic Streptococcus pyogenes infection isolates collected in San Francisco, California; Atlanta, Georgia; and Connecticut in 1994 and 1995.

Authors:  B Beall; R Facklam; T Hoenes; B Schwartz
Journal:  J Clin Microbiol       Date:  1997-05       Impact factor: 5.948

6.  Simplified protocol for pulsed-field gel electrophoresis analysis of Streptococcus pneumoniae.

Authors:  M C McEllistrem; J E Stout; L H Harrison
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

7.  Comparison of in vitro activities of ABT-773 and telithromycin against macrolide-susceptible and -resistant streptococci and staphylococci.

Authors:  Virginia D Shortridge; Ping Zhong; Zhensheng Cao; Jill M Beyer; Laurel S Almer; Nancy C Ramer; Stella Z Doktor; Robert K Flamm
Journal:  Antimicrob Agents Chemother       Date:  2002-03       Impact factor: 5.191

8.  Epidemiology of macrolide and/or lincosamide resistant Streptococcus pneumoniae clinical isolates with ribosomal mutations.

Authors:  Stella Z Doktor; Virginia D Shortridge; Jill M Beyer; Robert K Flamm
Journal:  Diagn Microbiol Infect Dis       Date:  2004-05       Impact factor: 2.803

9.  Clonal relatedness of erythromycin-resistant Streptococcus pyogenes isolates in Germany.

Authors:  Ralf R Reinert; Rudolf Lütticken; Joyce A Sutcliffe; Amelia Tait-Kamradt; Murat Y Cil; Holger M Schorn; André Bryskier; Adnan Al-Lahham
Journal:  Antimicrob Agents Chemother       Date:  2004-04       Impact factor: 5.191

10.  emm typing and validation of provisional M types for group A streptococci.

Authors:  R Facklam; B Beall; A Efstratiou; V Fischetti; D Johnson; E Kaplan; P Kriz; M Lovgren; D Martin; B Schwartz; A Totolian; D Bessen; S Hollingshead; F Rubin; J Scott; G Tyrrell
Journal:  Emerg Infect Dis       Date:  1999 Mar-Apr       Impact factor: 6.883

View more
  2 in total

1.  Differences in the DNA sequences in the upstream attenuator region of erm(A) in clinical isolates of Streptococcus pyogenes and their correlation with macrolide/lincosamide resistance.

Authors:  Stella Z Doktor; Virginia Shortridge
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

2.  MALDI-TOF mass spectrometry as a tool for differentiation of invasive and noninvasive Streptococcus pyogenes isolates.

Authors:  Hercules Moura; Adrian R Woolfitt; Maria G Carvalho; Antonis Pavlopoulos; Lucia M Teixeira; Glen A Satten; John R Barr
Journal:  FEMS Immunol Med Microbiol       Date:  2008-06-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.